Sapelo Pharma Private Limited

Sapelo Pharma Private Limited - business services in Chennai, Tamil Nadu, India. Directors, charges & compliance details.
CIN U47721TN2023PTC161245 Incorporated 16 June 2023 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Private Limited Company
Data last updated
Revenue · FY 2024
₹55.33 Lakh
Latest filing
Net loss · FY 2024
₹5.6 Lakh
Net margin -10.1%
EBITDA · FY 2024
-₹7.56 Lakh
EBITDA margin -13.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
3 yrs
Est. 2023
Directors on board
2
As per MCA filings
Last financials
Mar 2024
Balance sheet date

About Sapelo Pharma Private Limited

Data last updated:

Sapelo Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It was incorporated on 16 June 2023.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U47721TN2023PTC161245.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mohammed Aaquib Niyaz Ahmed Momin and Yiyang Li.

Its last annual general meeting (AGM) was held on 11 November 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Chennai, Tamil Nadu.

As per the financials filed for FY 2024, the company reported a revenue of ₹55.33 Lakh. For the same year it recorded a net loss of ₹5.6 Lakh (net margin -10.1%) and EBITDA of -₹7.56 Lakh (EBITDA margin -13.7%).

Company Details of Sapelo Pharma Private Limited
CIN U47721TN2023PTC161245
Registration Number 161245
Incorporation Date 16 June 2023
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 11 November 2024
Date of Balance Sheet 31 March 2024
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Shop No S101 Door No 769 Suite 45, Spencer Plaza, Chennai, Tamil Nadu, India – 600002
Comprehensive company report
Sapelo Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Sapelo Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Sapelo Pharma Private Limited in one report.

Financials from FY 2024 Directors & ownership Charges & compliance

Business Activity of Sapelo Pharma Private Limited

The main business activity of Sapelo Pharma is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
MProfessional, Scientific and TechnicalM9Other professional, scientific and technical activitiesLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Sapelo Pharma Private Limited FY 2024 filings available

Sapelo Pharma Private Limited reported revenue of ₹55.33 Lakh for FY 2024.

Revenue · FY 2024
₹55.33 Lakh
Net loss · FY 2024
₹5.6 Lakh margin -10.1%
EBITDA · FY 2024
-₹7.56 Lakh margin -13.7%

Financial Statement Summary of Sapelo Pharma Private Limited

MetricsFY 2023-24
Profit and Loss Statement
Revenue from Operations••••
Other Income••••
Total Revenue••••
Cost of Materials Consumed••••
Employee Benefit Expense••••
Finance Costs••••
Depreciation and Amortisation••••
Other Expenses••••
Total Expenses••••
EBITDA-₹7.56 Lakh
Profit Before Tax••••
Tax Expense••••
Net Profit (PAT)-₹5.6 Lakh
Balance Sheet
Share Capital••••
Reserves and Surplus••••
Net Worth (Total Equity)••••
Long-term Borrowings••••
Short-term Borrowings••••
Trade Payables••••
Total Liabilities••••
Fixed Assets••••
Investments••••
Inventories••••
Trade Receivables••••
Cash and Bank Balance••••
Total Assets••••

Financial Ratios of Sapelo Pharma Private Limited

MetricsFY 2023-24
Profitability
EBITDA Margin-13.7%
Net Profit Margin-10.1%
Return on Equity (ROE)••••
Return on Capital Employed (ROCE)••••
Return on Assets (ROA)••••
Liquidity and Debt
Current Ratio••••
Quick Ratio••••
Debt-to-Equity Ratio••••
Interest Coverage Ratio••••
Efficiency and Growth
Asset Turnover••••
Receivable Days••••
Payable Days••••
Inventory Days••••
Revenue Growth••••
Net Profit Growth••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sapelo Pharma are in the company report.

Premium access

Financial statements from FY 2024

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Sapelo Pharma Private Limited

Sapelo Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Enrich Life Sciences Private Limited₹55.61 Lakh (FY 2025)••••••••7.0%••••Vadodara, Gujarat, India
Indmag Remedies Private Limited₹55.52 Lakh (FY 2025)••••••••10.0%••••New Delhi, Delhi, India
Harsh Sales Private Limited₹55.48 Lakh (FY 2025)••••••••8.0%••••Indore, Madhya Pradesh, India
Sri Mookambika Sales Private Limited₹55.39 Lakh (FY 2022)••••••••-29.0%••••Bangalore, Karnataka, India
Saprem Distributors Private Limited₹55.36 Lakh (FY 2024)••••••••-65.0%••••Mumbai, Maharashtra, India
Sapelo Pharma Private Limited this company₹55.33 Lakh (FY 2024)••••••••••••Chennai, Tamil Nadu, India
Avayama Pharmacare Private Limited₹55.26 Lakh (FY 2024)••••••••310.0%••••Kolkata, West Bengal, India
MJ Herbal Extracts Private Limited₹55.24 Lakh (FY 2025)••••••••-25.0%••••Hyderabad, Telangana, India
Everest Laboratories Private Limited₹55.18 Lakh (FY 2025)••••••••-76.0%••••Ahmedabad, Gujarat, India
Medinews Pharma India Private Limited₹55.15 Lakh (FY 2024)••••••••-12.0%••••Erode, Tamil Nadu, India
Eos Pharmaceuticals India Limited₹55.13 Lakh (FY 2022)••••••••-35.0%••••New Delhi, Delhi, India

Peers are the five companies nearest above and the five nearest below Sapelo Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Board of Directors of Sapelo Pharma Private Limited

Sapelo Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Mohammed Aaquib Niyaz Ahmed MominDirector15 Nov 20241 Years 10 MonthsCurrent
Yiyang LiDirector16 Jun 20233 Years 3 MonthsCurrent

Charges & Borrowings of Sapelo Pharma Private Limited

Sapelo Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Sapelo Pharma Private Limited

Employment history and EPFO contributions of people linked to Sapelo Pharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Sapelo Pharma Private Limited

Sapelo Pharma Private Limited has 3 board changes on record since 2023: 2 appointments and 1 cessation. The latest: Mohammed Aaquib Niyaz Ahmed Momin was appointed as Director on 15 Nov 2024.

Appointed
Mohammed Aaquib Niyaz Ahmed Momin was appointed as Director.
Ceased
Syeda Rabia ceased to be Director.
AGM
Sapelo Pharma Private Limited last Annual general meeting of members was held on 11 Nov 2024 as per latest MCA records.
Filing
Sapelo Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Appointed
Yiyang Li was appointed as Director.
Incorporation
16 Jun 2023
Sapelo Pharma Private Limited was registered on 16 Jun 2023 with Roc Chennai & aged 3 years 3 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Sapelo Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Sapelo Pharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Sapelo Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Sapelo Pharma Private Limited

Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Sapelo Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sapelo Pharma Private Limited

Sapelo Pharma is an active private limited company based in Chennai, Tamil Nadu, India. It was incorporated on 16 June 2023 (3+ years old) and is registered under CIN U47721TN2023PTC161245.

Sapelo Pharma reported revenue of ₹55.33 Lakh for FY 2024.

Sapelo Pharma has 2 current directors:

Sapelo Pharma reported a net loss of ₹5.6 Lakh (net margin -10.1%) and EBITDA of -₹7.56 Lakh (EBITDA margin -13.7%) for FY 2024, as per its filed financial statements.

The CIN (Corporate Identification Number) of Sapelo Pharma is U47721TN2023PTC161245. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sapelo Pharma was incorporated on 16 June 2023, making it 3+ years old. It is registered with the Registrar of Companies, Chennai.

The peers of Sapelo Pharma by revenue are Enrich Life Sciences Private Limited, Indmag Remedies Private Limited, Harsh Sales Private Limited, Sri Mookambika Sales Private Limited, Saprem Distributors Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).

Mohammed Aaquib Niyaz Ahmed Momin was appointed as Director on 15 Nov 2024. Syeda Rabia ceased to be Director on 15 Nov 2024. Yiyang Li was appointed as Director on 16 Jun 2023.

The registered office of Sapelo Pharma is at Shop No S101 Door No 769 Suite 45, Spencer Plaza, Chennai, Tamil Nadu, India – 600002.

Sapelo Pharma has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.

No. Sapelo Pharma is not listed on any stock exchange. It is an unlisted company.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available